Global Huntingtons Disease Therapeutics Market Growth (Status and Outlook) 2026-2032

May 2026 | 116 pages | ID: G2BA17CAAE6CEN
LP Information

Abstracts

The global Huntingtons Disease Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Huntingtons Disease Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Huntingtons Disease Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Huntingtons Disease Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Huntingtons Disease Therapeutics players cover ValeantPharmaceuticals International lnc., Alnylam Pharmaceuticals Inc., AmpliPhi Biosciences Corp, Ceregene Inc.Lundbeck, Prana Biotechnology Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Huntingtons Disease Therapeutics Industry Forecast” looks at past sales and reviews total world Huntingtons Disease Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Huntingtons Disease Therapeutics sales for 2026 through 2032. With Huntingtons Disease Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Huntingtons Disease Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Huntingtons Disease Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Huntingtons Disease Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Huntingtons Disease Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Huntingtons Disease Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Huntingtons Disease Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Huntingtons Disease Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Psychotherapy
• Medical Treatement
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ValeantPharmaceuticals International lnc.
• Alnylam Pharmaceuticals Inc.
• AmpliPhi Biosciences Corp
• Ceregene Inc.Lundbeck
• Prana Biotechnology Limited
• Teva Pharmaceutical Industries Ltd.
• Cortex Pharmaceuticals lnc.
• VertexPharmaceuticals Incorporated
• Auspex Pharmaceuticals
• SOM Biotech
• GlaxoSmithKline
• Siena Biotech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Huntingtons Disease Therapeutics Market Size (2021-2032)
  2.1.2 Huntingtons Disease Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Huntingtons Disease Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Huntingtons Disease Therapeutics Segment by Type
  2.2.1 Psychotherapy
  2.2.2 Medical Treatement
  2.2.3 Others
  2.2.4 Huntingtons Disease Therapeutics Market Size by Type
    2.2.4.1 Huntingtons Disease Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Huntingtons Disease Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Huntingtons Disease Therapeutics Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Huntingtons Disease Therapeutics Market Size by Application
    2.3.4.1 Huntingtons Disease Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Huntingtons Disease Therapeutics Market Size Market Share by Application (2021-2026)

3 HUNTINGTONS DISEASE THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Huntingtons Disease Therapeutics Market Size Market Share by Player
  3.1.1 Global Huntingtons Disease Therapeutics Revenue by Player (2021-2026)
  3.1.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Huntingtons Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUNTINGTONS DISEASE THERAPEUTICS BY REGION

4.1 Huntingtons Disease Therapeutics Market Size by Region (2021-2026)
4.2 Global Huntingtons Disease Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Huntingtons Disease Therapeutics Market Size Growth (2021-2026)
4.4 APAC Huntingtons Disease Therapeutics Market Size Growth (2021-2026)
4.5 Europe Huntingtons Disease Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Huntingtons Disease Therapeutics Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Huntingtons Disease Therapeutics Market Size by Country (2021-2026)
5.2 Americas Huntingtons Disease Therapeutics Market Size by Type (2021-2026)
5.3 Americas Huntingtons Disease Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Huntingtons Disease Therapeutics Market Size by Region (2021-2026)
6.2 APAC Huntingtons Disease Therapeutics Market Size by Type (2021-2026)
6.3 APAC Huntingtons Disease Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Huntingtons Disease Therapeutics Market Size by Country (2021-2026)
7.2 Europe Huntingtons Disease Therapeutics Market Size by Type (2021-2026)
7.3 Europe Huntingtons Disease Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Huntingtons Disease Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Huntingtons Disease Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Huntingtons Disease Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUNTINGTONS DISEASE THERAPEUTICS MARKET FORECAST

10.1 Global Huntingtons Disease Therapeutics Forecast by Region (2027-2032)
  10.1.1 Global Huntingtons Disease Therapeutics Forecast by Region (2027-2032)
  10.1.2 Americas Huntingtons Disease Therapeutics Forecast
  10.1.3 APAC Huntingtons Disease Therapeutics Forecast
  10.1.4 Europe Huntingtons Disease Therapeutics Forecast
  10.1.5 Middle East & Africa Huntingtons Disease Therapeutics Forecast
10.2 Americas Huntingtons Disease Therapeutics Forecast by Country (2027-2032)
  10.2.1 United States Market Huntingtons Disease Therapeutics Forecast
  10.2.2 Canada Market Huntingtons Disease Therapeutics Forecast
  10.2.3 Mexico Market Huntingtons Disease Therapeutics Forecast
  10.2.4 Brazil Market Huntingtons Disease Therapeutics Forecast
10.3 APAC Huntingtons Disease Therapeutics Forecast by Region (2027-2032)
  10.3.1 China Huntingtons Disease Therapeutics Market Forecast
  10.3.2 Japan Market Huntingtons Disease Therapeutics Forecast
  10.3.3 Korea Market Huntingtons Disease Therapeutics Forecast
  10.3.4 Southeast Asia Market Huntingtons Disease Therapeutics Forecast
  10.3.5 India Market Huntingtons Disease Therapeutics Forecast
  10.3.6 Australia Market Huntingtons Disease Therapeutics Forecast
10.4 Europe Huntingtons Disease Therapeutics Forecast by Country (2027-2032)
  10.4.1 Germany Market Huntingtons Disease Therapeutics Forecast
  10.4.2 France Market Huntingtons Disease Therapeutics Forecast
  10.4.3 UK Market Huntingtons Disease Therapeutics Forecast
  10.4.4 Italy Market Huntingtons Disease Therapeutics Forecast
  10.4.5 Russia Market Huntingtons Disease Therapeutics Forecast
10.5 Middle East & Africa Huntingtons Disease Therapeutics Forecast by Region (2027-2032)
  10.5.1 Egypt Market Huntingtons Disease Therapeutics Forecast
  10.5.2 South Africa Market Huntingtons Disease Therapeutics Forecast
  10.5.3 Israel Market Huntingtons Disease Therapeutics Forecast
  10.5.4 Turkey Market Huntingtons Disease Therapeutics Forecast
10.6 Global Huntingtons Disease Therapeutics Forecast by Type (2027-2032)
10.7 Global Huntingtons Disease Therapeutics Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Huntingtons Disease Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 ValeantPharmaceuticals International lnc.
  11.1.1 ValeantPharmaceuticals International lnc. Company Information
  11.1.2 ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Product Offered
  11.1.3 ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 ValeantPharmaceuticals International lnc. Main Business Overview
  11.1.5 ValeantPharmaceuticals International lnc. Latest Developments
11.2 Alnylam Pharmaceuticals Inc.
  11.2.1 Alnylam Pharmaceuticals Inc. Company Information
  11.2.2 Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Product Offered
  11.2.3 Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Alnylam Pharmaceuticals Inc. Main Business Overview
  11.2.5 Alnylam Pharmaceuticals Inc. Latest Developments
11.3 AmpliPhi Biosciences Corp
  11.3.1 AmpliPhi Biosciences Corp Company Information
  11.3.2 AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Product Offered
  11.3.3 AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 AmpliPhi Biosciences Corp Main Business Overview
  11.3.5 AmpliPhi Biosciences Corp Latest Developments
11.4 Ceregene Inc.Lundbeck
  11.4.1 Ceregene Inc.Lundbeck Company Information
  11.4.2 Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Product Offered
  11.4.3 Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Ceregene Inc.Lundbeck Main Business Overview
  11.4.5 Ceregene Inc.Lundbeck Latest Developments
11.5 Prana Biotechnology Limited
  11.5.1 Prana Biotechnology Limited Company Information
  11.5.2 Prana Biotechnology Limited Huntingtons Disease Therapeutics Product Offered
  11.5.3 Prana Biotechnology Limited Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Prana Biotechnology Limited Main Business Overview
  11.5.5 Prana Biotechnology Limited Latest Developments
11.6 Teva Pharmaceutical Industries Ltd.
  11.6.1 Teva Pharmaceutical Industries Ltd. Company Information
  11.6.2 Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Product Offered
  11.6.3 Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
  11.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.7 Cortex Pharmaceuticals lnc.
  11.7.1 Cortex Pharmaceuticals lnc. Company Information
  11.7.2 Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Product Offered
  11.7.3 Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Cortex Pharmaceuticals lnc. Main Business Overview
  11.7.5 Cortex Pharmaceuticals lnc. Latest Developments
11.8 VertexPharmaceuticals Incorporated
  11.8.1 VertexPharmaceuticals Incorporated Company Information
  11.8.2 VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Product Offered
  11.8.3 VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 VertexPharmaceuticals Incorporated Main Business Overview
  11.8.5 VertexPharmaceuticals Incorporated Latest Developments
11.9 Auspex Pharmaceuticals
  11.9.1 Auspex Pharmaceuticals Company Information
  11.9.2 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Product Offered
  11.9.3 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Auspex Pharmaceuticals Main Business Overview
  11.9.5 Auspex Pharmaceuticals Latest Developments
11.10 SOM Biotech
  11.10.1 SOM Biotech Company Information
  11.10.2 SOM Biotech Huntingtons Disease Therapeutics Product Offered
  11.10.3 SOM Biotech Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 SOM Biotech Main Business Overview
  11.10.5 SOM Biotech Latest Developments
11.11 GlaxoSmithKline
  11.11.1 GlaxoSmithKline Company Information
  11.11.2 GlaxoSmithKline Huntingtons Disease Therapeutics Product Offered
  11.11.3 GlaxoSmithKline Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 GlaxoSmithKline Main Business Overview
  11.11.5 GlaxoSmithKline Latest Developments
11.12 Siena Biotech
  11.12.1 Siena Biotech Company Information
  11.12.2 Siena Biotech Huntingtons Disease Therapeutics Product Offered
  11.12.3 Siena Biotech Huntingtons Disease Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Siena Biotech Main Business Overview
  11.12.5 Siena Biotech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Huntingtons Disease Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Huntingtons Disease Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Psychotherapy
Table 4. Major Players of Medical Treatement
Table 5. Major Players of Others
Table 6. Huntingtons Disease Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Huntingtons Disease Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Huntingtons Disease Therapeutics Market Size Market Share by Type (2021-2026)
Table 9. Huntingtons Disease Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Huntingtons Disease Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Huntingtons Disease Therapeutics Market Size Market Share by Application (2021-2026)
Table 12. Global Huntingtons Disease Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Huntingtons Disease Therapeutics Revenue Market Share by Player (2021-2026)
Table 14. Huntingtons Disease Therapeutics Key Players Head office and Products Offered
Table 15. Huntingtons Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Huntingtons Disease Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Huntingtons Disease Therapeutics Market Size Market Share by Region (2021-2026)
Table 20. Global Huntingtons Disease Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Huntingtons Disease Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Huntingtons Disease Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Huntingtons Disease Therapeutics Market Size Market Share by Country (2021-2026)
Table 24. Americas Huntingtons Disease Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Huntingtons Disease Therapeutics Market Size Market Share by Type (2021-2026)
Table 26. Americas Huntingtons Disease Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Huntingtons Disease Therapeutics Market Size Market Share by Application (2021-2026)
Table 28. APAC Huntingtons Disease Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Huntingtons Disease Therapeutics Market Size Market Share by Region (2021-2026)
Table 30. APAC Huntingtons Disease Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Huntingtons Disease Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Huntingtons Disease Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Huntingtons Disease Therapeutics Market Size Market Share by Country (2021-2026)
Table 34. Europe Huntingtons Disease Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Huntingtons Disease Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Huntingtons Disease Therapeutics
Table 40. Key Market Challenges & Risks of Huntingtons Disease Therapeutics
Table 41. Key Industry Trends of Huntingtons Disease Therapeutics
Table 42. Global Huntingtons Disease Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Huntingtons Disease Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Huntingtons Disease Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Huntingtons Disease Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. ValeantPharmaceuticals International lnc. Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 47. ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Product Offered
Table 48. ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. ValeantPharmaceuticals International lnc. Main Business
Table 50. ValeantPharmaceuticals International lnc. Latest Developments
Table 51. Alnylam Pharmaceuticals Inc. Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 52. Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Product Offered
Table 53. Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Alnylam Pharmaceuticals Inc. Main Business
Table 55. Alnylam Pharmaceuticals Inc. Latest Developments
Table 56. AmpliPhi Biosciences Corp Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 57. AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Product Offered
Table 58. AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. AmpliPhi Biosciences Corp Main Business
Table 60. AmpliPhi Biosciences Corp Latest Developments
Table 61. Ceregene Inc.Lundbeck Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 62. Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Product Offered
Table 63. Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Ceregene Inc.Lundbeck Main Business
Table 65. Ceregene Inc.Lundbeck Latest Developments
Table 66. Prana Biotechnology Limited Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 67. Prana Biotechnology Limited Huntingtons Disease Therapeutics Product Offered
Table 68. Prana Biotechnology Limited Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Prana Biotechnology Limited Main Business
Table 70. Prana Biotechnology Limited Latest Developments
Table 71. Teva Pharmaceutical Industries Ltd. Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 72. Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Product Offered
Table 73. Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Teva Pharmaceutical Industries Ltd. Main Business
Table 75. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 76. Cortex Pharmaceuticals lnc. Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 77. Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Product Offered
Table 78. Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Cortex Pharmaceuticals lnc. Main Business
Table 80. Cortex Pharmaceuticals lnc. Latest Developments
Table 81. VertexPharmaceuticals Incorporated Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 82. VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Product Offered
Table 83. VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. VertexPharmaceuticals Incorporated Main Business
Table 85. VertexPharmaceuticals Incorporated Latest Developments
Table 86. Auspex Pharmaceuticals Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 87. Auspex Pharmaceuticals Huntingtons Disease Therapeutics Product Offered
Table 88. Auspex Pharmaceuticals Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Auspex Pharmaceuticals Main Business
Table 90. Auspex Pharmaceuticals Latest Developments
Table 91. SOM Biotech Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 92. SOM Biotech Huntingtons Disease Therapeutics Product Offered
Table 93. SOM Biotech Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. SOM Biotech Main Business
Table 95. SOM Biotech Latest Developments
Table 96. GlaxoSmithKline Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 97. GlaxoSmithKline Huntingtons Disease Therapeutics Product Offered
Table 98. GlaxoSmithKline Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. GlaxoSmithKline Main Business
Table 100. GlaxoSmithKline Latest Developments
Table 101. Siena Biotech Details, Company Type, Huntingtons Disease Therapeutics Area Served and Its Competitors
Table 102. Siena Biotech Huntingtons Disease Therapeutics Product Offered
Table 103. Siena Biotech Huntingtons Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Siena Biotech Main Business
Table 105. Siena Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Huntingtons Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Huntingtons Disease Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Huntingtons Disease Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Huntingtons Disease Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Huntingtons Disease Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Huntingtons Disease Therapeutics Market Size Market Share by Type in 2025
Figure 10. Huntingtons Disease Therapeutics in Hospital
Figure 11. Global Huntingtons Disease Therapeutics Market: Hospital (2021-2026) & ($ millions)
Figure 12. Huntingtons Disease Therapeutics in Clinic
Figure 13. Global Huntingtons Disease Therapeutics Market: Clinic (2021-2026) & ($ millions)
Figure 14. Huntingtons Disease Therapeutics in Others
Figure 15. Global Huntingtons Disease Therapeutics Market: Others (2021-2026) & ($ millions)
Figure 16. Global Huntingtons Disease Therapeutics Market Size Market Share by Application in 2025
Figure 17. Global Huntingtons Disease Therapeutics Revenue Market Share by Player in 2025
Figure 18. Global Huntingtons Disease Therapeutics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Huntingtons Disease Therapeutics Market Size 2021-2026 ($ millions)
Figure 20. APAC Huntingtons Disease Therapeutics Market Size 2021-2026 ($ millions)
Figure 21. Europe Huntingtons Disease Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Huntingtons Disease Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Americas Huntingtons Disease Therapeutics Value Market Share by Country in 2025
Figure 24. United States Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Huntingtons Disease Therapeutics Market Size Market Share by Region in 2025
Figure 29. APAC Huntingtons Disease Therapeutics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Huntingtons Disease Therapeutics Market Size Market Share by Application (2021-2026)
Figure 31. China Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Huntingtons Disease Therapeutics Market Size Market Share by Country in 2025
Figure 38. Europe Huntingtons Disease Therapeutics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Huntingtons Disease Therapeutics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Huntingtons Disease Therapeutics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Huntingtons Disease Therapeutics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Huntingtons Disease Therapeutics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Huntingtons Disease Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 54. APAC Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 55. Europe Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. United States Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Canada Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. China Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Japan Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Korea Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. India Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Australia Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Germany Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. France Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. UK Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Italy Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Russia Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Israel Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Global Huntingtons Disease Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Huntingtons Disease Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Huntingtons Disease Therapeutics Market Size 2027-2032 ($ millions)